Brief: 4D Molecular Therapeutics Q1 Net Income USD -32.401 Million Vs. IBES Estimate USD -35.8 Million
09/05/2024 21:05
May 09 (Reuters) - 4D Molecular Therapeutics Q1 operating expenses USD 38.164 million. * Q1 revenue USD 28 thousand vs. IBES estimate USD 785 thousand * Q1 basic EPS USD -0.66 * Q1 operating income USD -38.136 million vs. IBES estimate USD -37.6 million
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings